May 19, 2011 (Philadelphia, PA) - Neither low-dose aspirin nor simvastatin showed any clinical benefit in patients with pulmonary arterial hypertension (PAH) in the ASA-STAT study [1]. The study was ...
Baby aspirin just flunked the test of preventing cardiovascular problems, in a big way. The results of ARRIVE, or "Aspirin to Reduce Risk of Initial Vascular Events," were just announced at the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results